Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

May 13, 2019 Issue

09719-cover-sinclaircxd.jpg

May 13, 2019 Cover

Volume 97, Issue 19

As people live for decades with HIV, drugmakers respond with drugs that can be taken every few weeks

Cover image:A pair of hands holding pills and a syringe.

Credit: Will Ludwig/C&EN/Shutterstock

Full Article
Volume 97 | Issue 19

All Issues

Drug Development

With several long-acting HIV treatments in the works, the newest drugs emphasize convenience

As people live for decades with HIV, drugmakers respond with drugs that can be taken every few weeks

  • How to combat impostor syndrome

    Jen Heemstra on how to turn our negative thoughts into positive actions

  • Foghorn Therapeutics takes aim at chromatin hijackers to stop cancer

    The start-up, cofounded by Cigall Kadoch, is drugging a molecular machine called BAF, part of the chromatin regulatory system

  • A-STAR’s Jackie Ying wants academics to think more like entrepreneurs

    Head of NanoBio Lab aims to move inexpensive medical diagnostics from the lab bench to the market

ADVERTISEMENT
image name
Persistent Pollutants

Governments endorse global PFOA ban, with some exemptions

Restrictions placed on firefighting foam with PFOA, PFOS, or both

ADVERTISEMENT
ADVERTISEMENT